Suppr超能文献

锂治疗患者甲状腺疾病的横断面研究和前瞻性研究。

A cross-sectional and a prospective study of thyroid disorders in lithium-treated patients.

作者信息

Kirov George, Tredget John, John Rhys, Owen Michael J, Lazarus John H

机构信息

Department of Psychological Medicine, Cardiff University, Henry Wellcome Building, Heath Park, Cardiff CF14 4XN, Wales, UK.

出版信息

J Affect Disord. 2005 Aug;87(2-3):313-7. doi: 10.1016/j.jad.2005.03.010.

Abstract

BACKGROUND

The effects of lithium treatment on the thyroid gland have been demonstrated in a number of studies. Most of this research is based on cross-sectional studies and prospective studies are required to confirm these observations.

METHOD

During our genetic association studies, we recruited 115 males and 159 females suffering with affective disorders who had received lithium treatment. We observed longitudinally 57 of these patients, who attended our clinic for between 1 and 7 years and had no thyroid abnormalities at baseline. We performed regular checks of thyroid antibodies, thyroid function tests and lithium levels.

RESULTS

Hypo- and hyperthyroidism, including cases that developed prior to lithium treatment, were more common in women (25.8%) than in men (8.7%) and increased with age. By the age of 65, the risk in women increased to 50%. Hypothyroidism was induced by lithium in 17% women. In the prospective study, 4 out of 33 women developed hypothyroidism (an incidence of 27.4 cases per 1000 years). One woman developed thyrotoxicosis.

CONCLUSIONS

The risk for hypothyroidism induced by lithium is especially increased in women over the age of 50. Women should be warned of the risks involved when offered lithium treatment. The frequency of lithium-induced thyrotoxicosis is very low.

摘要

背景

多项研究已证实锂治疗对甲状腺的影响。大部分此类研究基于横断面研究,需要前瞻性研究来证实这些观察结果。

方法

在我们的基因关联研究中,我们招募了115名男性和159名患有情感障碍且接受过锂治疗的女性。我们对其中57名患者进行了纵向观察,这些患者在我们诊所就诊1至7年,基线时无甲状腺异常。我们定期检查甲状腺抗体、甲状腺功能测试和锂水平。

结果

甲状腺功能减退和亢进,包括锂治疗前就已出现的病例,在女性(25.8%)中比在男性(8.7%)中更常见,且随年龄增加而增加。到65岁时,女性的风险增至50%。17%的女性因锂导致甲状腺功能减退。在前瞻性研究中,33名女性中有4名出现甲状腺功能减退(每1000年发病率为27.4例)。一名女性出现甲状腺毒症。

结论

锂诱发甲状腺功能减退的风险在50岁以上女性中尤其增加。在为女性提供锂治疗时应告知其相关风险。锂诱发甲状腺毒症的发生率非常低。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验